*Helicobacter pylori*, a common human pathogen that infects about 50% of the world\'s population, is associated with duodenal ulcer and peptic ulcer diseases. Recent studies have shown that there is increased apoptosis of gastric epithelial cells during *H. pylori* infection.^[@bib1],\ [@bib2],\ [@bib3]^ Enhanced gastric epithelial cell apoptosis observed during infection with *H. pylori* is believed to be significant in the etiology of gastritis, peptic ulcers, and neoplasia. Recent studies have suggested that T cells are selectively increased during infection.^[@bib4],\ [@bib5],\ [@bib6],\ [@bib7]^ Cytokines like gamma interferon (IFN-*γ*) and tumor necrosis factor alpha (TNF-*α*) can increase the release of proinflammatory cytokines and augment apoptosis induced by *H. pylori*.^[@bib8]^ *H. pylori* infection could also induce damage to gastric mucosa by increasing the expression of Fas in gastric epithelial cells, leading to gastric epithelial cell apoptosis through Fas/FasL interaction with infiltrating T cells.^[@bib9],\ [@bib10]^ These findings suggest a role for immune-mediated apoptosis of gastric epithelial cells during *H. pylori* infection.

TRAIL (tumor necrosis factor-related apoptosis-inducing ligand; also called Apo2L), a novel TNF superfamily member with a strong homology to FasL, is capable of inducing apoptosis in a variety of transformed cell lines *in vitro*^[@bib11],\ [@bib12]^ but usually not in normal primary cells. It was recently shown that T cells kill target cells via TRAIL/TRAIL receptor interaction,^[@bib13],\ [@bib14],\ [@bib15]^ suggesting that TRAIL might serve as a cytotoxic effector molecule in activated T cells *in vivo*. Recent studies indicate that TRAIL-induced apoptosis occurs through a caspase signaling cascade and that resistance to TRAIL is controlled by intracellular regulators of apoptosis. The molecular events leading to apoptosis induction via TRAIL have recently been analyzed. Crosslinking of the TRAIL receptors leads to the formation of a death-inducing signaling complex (DISC).^[@bib16]^ The death adaptor protein FADD (MORT1) and the proteolytic enzymes caspase-8 and -10 are recruited to the TRAIL DISC.^[@bib17],\ [@bib18],\ [@bib19],\ [@bib20],\ [@bib21]^ Procaspase-8 is proteolytically cleaved and activated at the DISC. Activated caspase-8 then initiates the apoptosis executing caspase cascade. Previous studies demonstrated that TRAIL-induced apoptosis could be enhanced by *Helicobacter* and hepatitis C virus core protein.^[@bib22],\ [@bib23]^ However, the mechanisms leading to induce TRAIL sensitivity by microbes are not clear. Upregulation of the apoptosis-inducing TRAIL receptors after treatment with chemotherapeutic drugs and radiation has been implicated in sensitizing human leukemic and glioma cells.^[@bib24],\ [@bib25],\ [@bib26]^ It has been shown that chemotherapy-resistant tumor cells can be sensitized for TRAIL-induced apoptosis at the DISC level.^[@bib27]^ Here we report that human gastric epithelial cells sensitized to *H. pylori* confer susceptibility to TRAIL-mediated apoptosis. *H. pylori* induces TRAIL apoptosis signaling by downregulation of FLICE-inhibitory protein (FLIP), which enhances the assembly of TRAIL DISC, induces caspase-8 activation, and conveys the death signal to mitochondria, resulting in a breakdown of apoptosis resistance.

Results
=======

*H. pylori* enhances sensitivity to TRAIL-mediated apoptosis in human gastric epithelial cell lines via activation of caspase-8 and its downstream pathway
----------------------------------------------------------------------------------------------------------------------------------------------------------

TRAIL has been shown to induce apoptosis in a number of different tumor cell types but not usually in normal primary cells. To examine a role for TRAIL-induced apoptosis in gastric epithelial cells, recombinant TRAIL proteins were used to induce apoptosis in human gastric epithelial cell lines (AGS). The results revealed that AGS cells were resistant to TRAIL-mediated apoptosis. We further studied TRAIL-induced apoptosis in gastric epithelial cells after interaction with *H. pylori*. In the absence of TRAIL, *H. pylori* induced only mild apoptosis in AGS cells; however, apoptosis was markedly induced after adding TRAIL, and induction of TRAIL-mediated apoptosis by *H. pylori* was specifically blocked by adding soluble TRAIL receptor, death receptor 4 (DR4)-Fc, indicating that cell death resulted from the interaction between TRAIL and the TRAIL receptor on the cell surface ([Figure 1a](#fig1){ref-type="fig"}).

To further delineate the intracellular signal transduction pathway modulated by *H. pylori* that results in induction of TRAIL-sensitivity, we investigated the activation of caspase pathways following TRAIL engagement and subsequent to *H. pylori* interaction. In the absence of *H. pylori*, TRAIL engagement only induced a slight activation of caspase-8 but not caspase-3 in AGS cells. In contrast, during TRAIL engagement, both caspase-8 and caspase-3 were fully activated in AGS cells, resulting in cell apoptosis after exposure to *H. pylori* ([Figure 1b](#fig1){ref-type="fig"}). Furthermore, the ability to induce TRAIL sensitivity in AGS cells by *H. pylori* was significantly suppressed by the caspase-8 inhibitor, Z-IETD-fmk; pan-caspase inhibitor, Z-VAD-fmk; or the caspase-3 inhibitor, DEVD-fmk. ([Figure 1c](#fig1){ref-type="fig"}) In addition, the *H. pylori*-induced TRAIL sensitivity in AGS cells was significantly suppressed by knocking down caspase-8 ([Figure 1d](#fig1){ref-type="fig"}).

To exclude the possibility that the *H. pylori*-induced sensitivity to TRAIL in gastric epithelial cell lines is due to upregulation of TRAIL DRs, we further examined the expression of TRAIL receptors before and after interaction with *H. pylori*. The results demonstrated that expression of TRAIL receptors on the gastric cell surface did not appear significantly different before and after interaction with *H. pylori* ([Figure 2](#fig2){ref-type="fig"}). Taken together, the results indicate that *H. pylori* enhances TRAIL-mediated apoptosis in gastric epithelial cell lines by modulating intracellular death signal transduction by activation of a caspase-8 downstream cascade. In so doing, the pathogen alters the intracellular regulation of resistance to DR-induced apoptosis through a pathway involving the sequential induction of apical caspase-8 activity, caspase cascade, and effector caspase-3 activity.

*H. pylori* induces the activation of the mitochondrial signaling pathway after TRAIL engagement
------------------------------------------------------------------------------------------------

For detecting caspase processing events distal to caspase-8 activation, we investigated the activation of mitochondria after exposure to *H. pylori* in AGS cells. To examine the changes of mitochondrial membrane potential (Δ*ψ*m) after TRAIL engagement, the Δ*ψ*m was detected by the uptake of 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetrathylbenzimidazolyl carbocyanine iodide (JC-1) dye.^[@bib28],\ [@bib29]^ The results ([Figure 3](#fig3){ref-type="fig"}) demonstrate that TRAIL engagement induced a breakdown in the transmembrane potential of mitochondria after interaction with *H. pylori* but not in the absence of *H. pylori*, consistent with the difference in caspase-3 activation. To further confirm the induction of mitochondrial signaling pathway by TRAIL, we also analyzed cytochrome *c* released from mitochondria into cytoplasm after TRAIL engagement. The results ([Figure 3](#fig3){ref-type="fig"}) demonstrate that TRAIL engagement induced the release of cytochrome *c* from mitochondria to cytosol and activated the mitochondria downstream caspase cascade, caspase-9, in AGS cells in the presence of *H. pylori*. In addition, the induction of TRAIL sensitivity in AGS cells by *H. pylori* was significantly inhibited in the presence of the caspase-9 inhibitor Z-LEHD-fmk ([Figure 3d](#fig3){ref-type="fig"}), indicating that activation of the mitochondria downstream pathway was required in TRAIL-mediated apoptosis in AGS cells induced by *H. pylori*.

To investigate the role of the mitochondria apoptosis signaling pathway in *H. pylori*-induced TRAIL sensitivity, we further transfected Bcl-2 into AGS cells to establish stable transfectants. The results ([Figure 4a](#fig4){ref-type="fig"}) demonstrate that the overexpression of Bcl-2 in AGS cells inhibited the induction of TRAIL sensitivity in AGS cells by *H. pylori.* Taken together, our results indicate that *H. pylori* induces a sensitivity to TRAIL-mediated apoptosis in gastric epithelial cell lines through a pathway involving the activation of caspase-8 downstream signaling pathway to convey the death signal to mitochondria, leading to activation of the mitochondrial apoptosis signaling pathway and eliminating resistance to apoptosis.

*H. pylori* induces sensitivity to TRAIL-mediated apoptosis and activates the mitochondrial signaling pathway via Bid cleavage after TRAIL engagement
-----------------------------------------------------------------------------------------------------------------------------------------------------

The finding that TRAIL engagement induces cytochrome *c* release and caspase-9 activation in AGS cells in the presence of *H. pylori* indicates that apoptosis signals are conveyed from the TRAIL DR to mitochondria in AGS cells after interaction with *H. pylori*. For detecting the caspase processing events distal to caspase-8, which connects caspase-8 with mitochondria, we further investigated the processing of Bid after TRAIL engagement. The results ([Figure 4b](#fig4){ref-type="fig"}) demonstrate that *H. pylori* enhanced TRAIL-induced Bid cleavage in AGS cells, which is consistent with activation of the mitochondrial signaling pathway and caspase-3 after TRAIL engagement. In addition, the *H. pylori*-induced TRAIL sensitivity in AGS cells was significantly suppressed by knocking down Bid ([Figure 4c](#fig4){ref-type="fig"}). Taken together, our results indicate that the induction of TRAIL sensitivity by *H. pylori* is dependent on the sequential activation of the caspase-8 downstream pathway, enhancing the cleavage of Bid, activating the mitochondrial signaling pathway, and breaking resistance to apoptosis.

*H. pylori* enhances the assembly of the TRAIL DISC through reduction of FLIP recruitment
-----------------------------------------------------------------------------------------

The expression of DR4 and DR5 DRs was not upregulated by *H. pylori*, and results indicate that *H. pylori* enhances TRAIL-mediated apoptosis in gastric epithelial cell lines by modulating intracellular death signal transduction. We then investigated the possible involvement of FLIP in regulating the assembly of TRAIL DISC in the presence or absence of *H. pylori*. Cells were co-cultured with *H. pylori* and then stimulated with FLAG-TRAIL. After TRAIL engagement, the cell lysate was co-immunoprecipitated with an anti-FLAG monoclonal antibody (mAb), and the isolated receptor complexes were analyzed for TRAIL DISC via western blotting. The results ([Figure 5](#fig5){ref-type="fig"}) demonstrate that *H. pylori* enhanced the activation of caspase-8 during TRAIL engagement in a dose-dependent manner in human gastric epithelial cells ([Figure 5a](#fig5){ref-type="fig"}). When we investigated the assembly of the TRAIL DISC after TRAIL engagement in the presence or absence of *H. pylori* via co-immunoprecipitation experiments, the results ([Figure 5b](#fig5){ref-type="fig"}) demonstrate that, in the absence of *H. pylori*, TRAIL induced the assembly of DR5 (TRAIL-R2), FADD (MORT1), FLIP, and a small amount of caspase-8 in the DISC. In contrast, *H. pylori* significantly enhanced the recruitment of caspase-8 into the TRAIL DISC through reduction of the FLIP assembly and therefore augmented the activation of caspase-8. Our results indicate that *H. pylori* enhances the assembly of the TRAIL DISC and activation of caspase-8 via inhibition of FLIP recruitment into the TRAIL DISC.

Sensitization of TRAIL-induced apoptosis by *H. pylori* is mediated by downregulation of c-FLIP[S]{.smallcaps}
--------------------------------------------------------------------------------------------------------------

Our results indicate that *H. pylori* enhances the assembly of the TRAIL DISC by inhibiting the recruitment of FLIP into the DISC. To further confirm the role of FLIP in *H. pylori*-induced TRAIL sensitivity in human gastric epithelial cells, AGS cells were transfected with FLIP[S]{.smallcaps}, co-cultured with *H. pylori*, and then subjected to treatment with TRAIL. The results ([Figure 6](#fig6){ref-type="fig"}) demonstrate that TRIAL sensitivity induced by *H. pylori* is completely abolished by FLIP[S]{.smallcaps} overexpression. In addition, the amount of the FLIP[S]{.smallcaps} protein was decreased when cells interacted with *H. pylori*. In contrast, when cells were pretreated with a proteosome inhibitor MG132 for 30 min before the incubation of *H. pylori*, the decrease in c-FLIP[S]{.smallcaps} protein was inhibited ([Figure 6b](#fig6){ref-type="fig"}), indicating that *H. pylori* induced the degradation of FLIP[S]{.smallcaps}, leading to a decrease in the recruitment of FLIP into the DISC.

To further confirm the role of FLIP in regulating *H. pylori*-induced TRAIL sensitivity in human gastric epithelial cells, AGS cells were transfected with c-FLIP[S]{.smallcaps} siRNA to knock down the expression of FLIP[S]{.smallcaps} and co-cultured with *H. pylori* followed by treatment with TRAIL. The results ([Figure 7](#fig7){ref-type="fig"}) demonstrate that the knockdown of endogenous c-FLIP[S]{.smallcaps} markedly enhances TRAIL-induced apoptosis. In addition, the knockdown of c-FLIP[S]{.smallcaps} induced the cleavage of caspase-8, Bid, caspase-9, and caspase-3 after TRAIL engagement. Taken together, our results indicated that *H. pylori* enhances TRAIL sensitivity in human gastric epithelial cells via a decrease in FLIP recruitment into the DISC, leading to the activation of caspase-8 and its downstream pathway, thus breaking TRAIL resistance.

Discussion
==========

Our studies indicate that *H. pylori* induces TRAIL apoptosis signaling by downregulating FLIP, which enhances the assembly of DISC, induces maximal caspase-8 activation and conveys the death signal to mitochondria, leading to a breakdown in apoptosis resistance. Collectively, our findings uncover a novel mechanism of modulation of TRAIL resistance mediated by *H. pylori* through regulation of the DISC and provides strong evidence that *H. pylori* modulates the transduction of the host cell death signal via downregulation of FLIP.

We demonstrated in previous reports that human gastric epithelial cells sensitized to *H. pylori* confer susceptibility to TRAIL-mediated apoptosis, suggesting a role for immune-mediated apoptosis of gastric epithelial cells by infiltrating T cells during *Helicobacter* infection.^[@bib6],\ [@bib22]^ The induction of TRAIL sensitivity by *H. pylori* is independent of the expression of *H. pylori* virulent factors Vac A and Cag A and is dependent on viable bacteria and direct contact with cells.^[@bib22]^ The role of TRAIL DR DR5 (TRAIL-R2) in the regulation of TRAIL-induced apoptosis has been evaluated recently in several tumor cell lines.^[@bib30],\ [@bib31],\ [@bib32],\ [@bib33],\ [@bib34]^ In our study, the expression of TRAIL receptors did not change after *H. pylori* infection, indicating that the *H. pylori-*induced enhanced sensitivity to TRAIL-mediated apoptosis in gastric epithelial cells is not due to upregulation of TRAIL DRs, DR5 in particular ([Figure 2](#fig2){ref-type="fig"}). Thus, instead of the induction of DR upregulation, *H. pylori* induces TRAIL sensitivity in gastric epithelial cells via modulation of DR signal transduction pathways.

*H. pylori* induces sensitivity to TRAIL-mediated apoptosis in gastric epithelial cells through a pathway involving the sequential induction of apical caspase-8 and effector caspase-3 activity via activation of a mitochondrial pathway. Our results suggest that the type II pathway is mainly involved in TRAIL-induced apoptosis in human gastric epithelial cells where mitochondria have an important role in amplifying apoptotic signals. Our results also indicate that *H. pylori* induces the mitochondrial apoptosis pathway via FLIP downregulation, which enhances DISC assembly after TRAIL engagement and further induces the activation of caspase-8 and cleavage of Bid. c-FLIP proteins have an essential role in the regulation of DR-induced apoptosis. Among the three isoforms: c-FLIP long (c-FLIP~L~, 55 kDa), c-FLIP short (c-FLIP[S]{.smallcaps}, 27 kDa), and c-FLIP Raji (c-FLIP~R~, 25 kDa),^[@bib35],\ [@bib36],\ [@bib37]^ c-FLIP[S]{.smallcaps} is a well-described inhibitor of DR-mediated apoptosis.^[@bib35],\ [@bib36],\ [@bib37],\ [@bib38]^ It has been shown that c-FLIP[S]{.smallcaps} blocks Fas^[@bib35],\ [@bib36],\ [@bib37],\ [@bib38]^ as well as TRAIL^[@bib35]^ induced apoptosis via binding to the DISC and inhibiting procaspase-8 processing and activation at the DISC.^[@bib35],\ [@bib36],\ [@bib37],\ [@bib38]^ However, the effect of the c-FLIP~L~ isoform on DR-mediated apoptosis is still controversial. Our results demonstrated that *H. pylori* modulated the amounts of c-FLIP[S]{.smallcaps}; and overexpression of c-FLIP[S]{.smallcaps} abolished the effects of *H. pylori*-induced TRAIL sensitivity in AGS cells. Therefore, our study indicates that short c-FLIP[S]{.smallcaps} isoform modulates TRAIL apoptosis signaling in human gastric epithelial cells.

During *H. pylori* infection, the degree of apoptosis induced in the stomach is affected by the inflammatory response. *H. pylori* infection induces a T-cell response and a number of inflammatory mediators, including cytokines and chemokines.^[@bib4],\ [@bib5],\ [@bib6],\ [@bib7],\ [@bib39],\ [@bib40]^ These infiltrating T cells can then kill gastric target cells via TRAIL/TRAIL receptor interaction. In addition to its role in inducing apoptosis by binding to DRs, TRAIL itself can stimulate T cell after T-cell receptor (TCR) engagement and augment IFN-*γ* secretion.^[@bib41],\ [@bib42],\ [@bib43]^ Our results, combined with recent evidence, therefore support the functional role of TRAIL in *H. pylori*-induced apoptosis. However, the degree of apoptosis during gastric inflammation is linked to the presence of *H. pylori* and the associated inflammatory response. Therefore, the degree of mucosal damage not only depends on the virulence of *H. pylori* but is also determined by the inflammatory response that is induced by *H. pylori* within the gastric epithelium.

Recently, several bacterial pathogens have been found to trigger apoptosis in host cells *in vitro* or *in vivo*, and several types of mechanisms have been elucidated.^[@bib44]^ Recent reports have shown that *H. pylori* can secrete CagA into gastric epithelial cell by Type IV secretion, inducing intracellular protein phosphorylation in host cells,^[@bib45],\ [@bib46],\ [@bib47],\ [@bib48]^ suggesting that *H. pylori* can modulate intracellular signaling via factors secreted into host cells. However, in our previous study we demonstrated that induction of TRAIL sensitivity by *H. pylori* is independent of *H. pylori* virulent factors Vac A and Cag A.^[@bib22]^ Therefore, the bacterial factors leading to induction of TRAIL sensitivity by *H. pylori* is still not clear, and it awaits further investigation. Taken together, our results indicate that *H. pylori* modulates the sensitivity to TRAIL-mediated apoptosis in gastric epithelial cells by the induction of FLIP downregulation, which enhances DISC assembly, further induces caspase-8 activation, and conveys the death signal to mitochondria, resulting in a breakdown of apoptosis resistance and causing gastric mucosal damage during inflammation. Thus, modulation of host cell death signal transduction by bacterial interaction adds a new dimension to the immune pathogenesis in chronic *Helicobacter* infection.

Materials and Methods
=====================

Bacterial strains, cell lines, and media
----------------------------------------

*H. pylori* strains ATCC 43504 were obtained from American Type Culture Collections (ATCC, Manassas, VA, USA). Before each experiment, *H*. *pylori* was passaged on 5% sheep blood agar plates by incubation in an atmosphere consisting of 5% O~2~, 15% CO~2~, and 80% N~2~ for 2--4 days at 37 °C. Bacteria were cultured in brucella broth (Difco Labs, Detroit, MI, USA) supplemented with 5% FBS, vancomycin and amphotericin B under the same condition for 30 h at 37 °C with agitation (80--100 r.p.m.). Cells were then pelleted and resuspended in phosphate-buffered saline at a concentration of 10^8^ CFU/ml. The human gastric adenocarcinoma cell lines AGS were obtained from ATCC and maintained in Dulbecco modified essential medium (DMEM), supplemented with 10% FBS.

Expression and purification of recombinant TRAIL protein and soluble TRAIL receptor DR4-Fc
------------------------------------------------------------------------------------------

The recombinant TRAIL proteins were expressed in the *Escherichia coli* expression system and purified with a Ni column.^[@bib41]^ In brief, the coding portion of the extracellular domain of TRAIL (amino acids 123--314) was PCR-amplified, subcloned into pRSET B vector (Invitrogen, Groningen, Netherlands), and expressed in the *E. coli* expression system. The purification of recombinant His-TRAIL fusion protein was performed by metal chelate column chromatography using Ni-NTA resin according to the manufacturer\'s recommendations (Qiagen, Hilden, Germany). His-TRAIL was quantified by the Bradford method and protein assay reagent (BioRad, Richmond, CA, USA). To generate soluble recombinant DR4-Fc fusion molecules, the coding sequence for the extracellular domain of human DR4 was isolated by RT-PCR using the forward primer, 5′-CGGATTTCATGGCGCCACCACCA-3′ and the reverse primer, 5′-GAAGATCTATTATGTCCATTGCC-3′. The amplified product was ligated in-frame into *Bam*HI-cut pUC19-IgG1-Fc vector containing the human IgG1 Fc coding sequence. The fusion gene was then subcloned into pBacPAK9 vector (Clontech, Palo Alto, CA, USA). DR4-Fc fusion protein was recovered from the filtered supernatants of the recombinant virus-infected Sf21 cells using protein G-Sepharose beads (Pharmacia, Piscataway, NJ, USA). The bound DR4-Fc protein was eluted with glycine buffer (pH 3) and dialyzed into PBS.

Apoptosis assay
---------------

A sensitive ELISA assay, which detects cytoplasmic histone-associated DNA fragments, was performed according to the manufacturer\'s protocol (Cell Death Detection ELISA^PLUS^; Roche Mannheim Biochemicals, Mannheim, Germany). This was cultured overnight in a 96-well plate at 10^4^ gastric epithelial cells/well, treated with TRAIL recombinant protein for 4 h, and harvested by centrifugation at 200 × *g*. Cells were lysed by incubation with lysis buffer for 30 min, followed by centrifugation at 200 × *g* for 10 min at room temperature. The supernatant was collected and incubated with immunoreagent that was prepared 2 h beforehand. After washing gently, the supernatant was pipetted into each well along with the substrate solution and kept in the dark until it developed sufficient color for photometric analysis. The reaction was determined in a spectrophotometer at 405 nm. Caspase inhibitors were used in some experiments. Caspase-8, caspase-3, or caspase-9 inhibitors were applied at a concentration of 10 *μ*M to the medium 30 min before treatment.

Flow cytometry
--------------

AGS cells were resuspended in 90 *μ*l FACS staining buffer (1% FCS in PBS), incubated with various fluorochrome-conjugated antigen-specific antibodies (anti-DR4, -DR5, -DcR1 (decoy receptor 1) and -DcR2) (eBioscience, San Diego, CA, USA) at 4 °C for 30 min, and followed by washing twice with 1 ml of FACS staining buffer. Cell fluorescence intensity was detected by a FACScan and analyzed by the CellQuest software.

Detection of Δ*ψ*m
------------------

To detect the changes in Δ*Ψ*m, AGS cells were seeded at 10^6^ cells/ml into a 6-well plate and grown in DMEM supplemented with 10% fetal calf serum in a 95% air--5% CO~2~ atmosphere at 37 °C in a humidified incubator overnight. Cells were co-cultured with HP strain 51932 at a concentration of 5 × 10^8^ CFU/ml for 12 h and treated with 1.5 *μ*g/ml TRAIL recombinant protein for another 12 h. Mitochondrial injury and changes in the Δ*ψ*m were assessed by staining with JC-1 (Molecular Probes, Eugene, OR, USA). This dye, existing as a monomer in solution, emits a green fluorescence and can assume a dimeric configuration that emits red fluorescence in a reaction that is driven by the mitochondrial transmembrane potential.^[@bib28]^ Thus, red fluorescence indicates intact mitochondria, whereas green fluorescence shows monomeric JC-1 that remained unprocessed due to breakdown of the mitochondrial transmembrane potential. After trypsinization by TEG buffer (0.125% trypsin, 0.05% EDTA, 0.05% glucose in PBS), the cells were resuspended in DMEM and incubated with JC-1 10 *μ*g/ml for 15 min at 37 °C. Cells were washed with PBS twice and resuspended in PBS. Analysis was performed by a FACS scan, and mitochondrial function was assessed as JC-1 green (uncoupled mitochondria) or red (intact mitochondria) fluorescence.^[@bib29]^ For confocal laser scanning microscopy analysis of mitochondrial function, the JC-1-treated cells were excited at 488 nm, and emissions were simultaneously recorded at 527 and 590 nm into an independent detector.

Preparation of cytosols, analysis of cytochrome *c* release, and Bid cleavage
-----------------------------------------------------------------------------

After incubation with TRAIL, cells were washed twice with ice-cold PBS. They were suspended in 100 *μ*l of extraction buffer (50 mM PIPES-KOH, pH 7.4, 220 mM mannitol, 68 mM sucrose, 50 mM KCl, 5 mM EGTA, 2 mM MgCl2, 1 mM dithiothreitol, and protease inhibitors) and allowed to swell on ice for 30 min. Cells were homogenized by passing the suspension through a 25-gauge needle (10 strokes). Homogenates were centrifuged at 14 000 × *g* for 15 min at 4 °C, and the supernatants were harvested and stored at −80 °C. The protein content of the cytosols was determined by the Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA, USA). For the analysis of cytochrome *c* release, 10 *μ*g of cytosolic protein was loaded per lane. Proteins were separated on 12% SDS-PAGE and transferred to nitrocellulose sheets, which were blocked for 1 h in PBS and 0.05% Tween 20 with 5% dry milk. Blots were probed in PBS and 0.05% Tween 20, with anti-cytochrome *c* mAb (eBioscience) or anti-Bid polyclonal Ab (Cell Signaling, Beverly, MA, USA) and secondary antibodies. The immunoblots were checked with anti-*β* actin mAb to ensure equal loading.

Immunoblot analysis
-------------------

Cells (5 × 10^5^/ml) were washed twice with ice-cold PBS, scraped from their 6-cm culture dishes into 1 ml ice-cold PBS, and centrifuged at 1000 × *g* for 5 min. The resultant pellets were incubated with RIPA lysis buffer (150 mM NaCl, 50 mM Tris-HCl (pH 8.0), 1% NP40, 0.1% SDS, 0.5% sodium deoxycholateor, 10 mg/ml phenylmethylsulfonyl fluoride, and 10 mg/ml aprotinin) for 30 min on ice. The cell lysates were centrifuged, and the supernatant was stored at −80 °C until used. The protein concentrations of the extracts were measured with protein assay reagent. The extracted cell lysates (50 *μ*g) were subjected to SDS-PAGE and transferred onto PVDF. The membrane was blocked in 5% nonfat skim milk or 5% BSA in TBST (100 mM Tris-HCl at pH 7.4, 9% NaCl, 2% Tween-20) at room temperature for 30 min and incubated with mouse mAb against caspase-3 (Imgenex, San Diego, CA, USA), caspase-8 (Cell Signaling Technology, Danvers, CO, USA), FLIP (ENZO Life Sciences, Farmingdale, NY, USA), and actin (Chemicon International, Temecula, CA, USA) or rabbit polyclonal antibody against caspase-9, cytochrome *c*, Bid (Cell Signaling Technology), FADD (ENZO Life Sciences), and DR5 (Chemicon International). Bound primary antibodies were detected with an anti-mouse IgG or anti-rabbit IgG conjugated with HRP (Cell Signaling Technology), and the bands were visualized using the enhanced chemiluminescence method (Perkin-Elmer, Waltham, MA, USA). The expression of actin was used to verify equal loading in all studies.

DISC immunoprecipitation
------------------------

For co-immunoprecipitation of TRAIL DISC, 5 × 10^6^ AGS cells were used per sample. Cells were seeded onto 10-cm dishes, incubated overnight with *H. pylori* cells for 12 h, and harvested at 1300 r.p.m. for 5 min. Cells were resuspended with 500 *μ*l RPMI medium, treated with 0.5 *μ*g Flag-TRAIL (ENZO Life Sciences) combined with 1 *μ*g anti-Flag mAb, M2 (Sigma-Aldrich, St. Louis, MO, USA) or normal mouse IgG (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and the mixture was incubated on an end-over-end rotator at room temperature for 1 h. PBS (5 ml) was added to the mixture with 10 × volume of ice, and the cells were collected by centrifugation at 1300 r.p.m. at 4 °C. The cells were lysed with 1000 *μ*l cold lysis buffer with 10 *μ*M Z-VAD-fmk for 30 min at 4 °C. The resulting protein complexes were precipitated from the lysates by adding protein A agarose and then incubated for 1 h at 4 °C. Each sample was washed three times with lysis buffer at 4 °C. Isolated receptor complexes (IP) were assessed for caspase-8, FLIP[S]{.smallcaps}, FADD, and DR5 by western blotting.
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![*H. pylori* enhances sensitivity to TRAIL-mediated apoptosis in human gastric epithelial cell lines via activation of caspase-8 and its downstream pathway. (**a**) Human gastric epithelial cell line AGS were co-cultured with *H. pylori* for 12 h and incubated with recombinant TRAIL proteins in the presence or absence of soluble TRAIL receptor, DR4-Fc protein, for 12 h. Cell apoptosis was measured by cell death enzyme-linked immunosorbent assay (ELISA). Values represent means±S.D. of three independent experiments (\**P*\<0.05). (**b**) AGS cells were co-cultured with *H. pylori* for 12 h and incubated with recombinant TRAIL proteins for the indicated times. Cell lysates were subjected to western blotting analysis for detection of caspase activation. The native forms of caspase-8 and caspase-3 are 55/54 and 32 kDa, respectively. The cleaved forms of caspase-8 are 43/41 and 18 kDa, respectively. The cleaved forms of caspase-3 are 19 and 17 kDa, respectively. The expression of actin serves as a loading control. CASP, caspase. (**c**) AGS cells were co-cultured with *H. pylori* for 12 h in the presence of pan-caspase inhibitor, Z-VAD-fmk (Bachem, Bubendorf, Sweden), specific caspase-8 inhibitor, Z-IETD-fmk, or specific caspase-3 inhibitor, Z-DEVD-fmk (Calbiochem, San Diego, CA, USA) and then were treated with recombinant TRAIL proteins for 4 h. Cell apoptosis was measured by cell death ELISA. Values represent means±S.D. of three independent experiments (\**P*\<0.05). (**d**) AGS cells were transfected with scramble or caspase-8 siRNA, followed by incubating with *H. pylori* for 12 h and subsequently treated with TRAIL for 4 h. Cell apoptosis was measured by cell death ELISA. Values represent means±S.D. of three independent experiments (\**P*\<0.05)](cddis201481f1){#fig1}

![*H. pylori*-induced TRAIL sensitivity in gastric epithelial cells is not due to upregulation of DRs. AGS Cells were incubated with or without *H. pylori* for 12 h and then the expression of TRAIL receptors, DR4, DR5, DcR1, and DcR2, on cell surfaces were analyzed by flow cytometry with mAbs against DR4, DR5, DcR1, and DcR2 (eBioscience) or isotype antibody (shaded histogram). The human granulocytes served as positive controls for DcR1 and DcR2](cddis201481f2){#fig2}

![*H. pylori* induces activation of the mitochondrial pathway after TRAIL engagement. (**a** and **b**) Changes in mitochondrial transmembrane potential were assessed as JC-1 green (uncoupled mitochondria) or red (intact mitochondria) fluorescence. Green fluorescence of JC-1 dye was assessed as a parameter for mitochondrial breakdown. (**a**) AGS cells were labeled with the mitochondrial transmembrane potential-sensitive dye JC-1 and treated with recombinant TRAIL in the presence or absence of *H. pylori*. The JC-1 green (uncoupled mitochondria) or red (intact mitochondria) fluorescence was visualized under a confocal microscope. Reduced red fluorescence with increased green fluorescence was observed in AGS cells treated with TRAIL in the presence of *H. pylori.* There were 100 cells analyzed per field by confocal microscopy, and this is a representative sample. (**b**) AGS cells were labeled with JC-1 and treated with recombinant TRAIL in the presence or absence of *H. pylori*. Analysis was performed by a FACS scan. Increased green fluorescence was detectable in AGS cells treated with recombinant TRAIL after exposure to *H. pylori* (thick line) and compared with AGS cells treated with TRAIL but without exposure to *H. pylori* (thin line). Shaded histogram: AGS alone. (**c**) *H. pylori* induces the release of cytochrome *c* from mitochondria after TRAIL engagement. AGS cells (10^6^ cells) were incubated with 1 g/ml recombinant TRAIL proteins for various times as indicated in the absence or presence of *H. pylori*, and the cytoplasmic fraction of the cell lysate was isolated. Cytoplasmic proteins were separated by SDS-PAGE and then transferred to a nitrocellulose membrane. Cytochrome *c* released from mitochondria into the cytoplasm was detected with specific anti-cytochrome *c* and anti-caspase-9 mAbs (Cell Signaling Technology). The native form of caspase-9 is 47 kDa, and cleaved forms are 37 kDa and 35 kDa. Membranes were also blotted with anti-*β*-actin mAb as a loading control. The results were representative of at least three independent experiments. (**d**) AGS Cells were co-cultured with *H. pylori* and treated with caspase-9 inhibitor, Z-LEHD-fmk, followed by treatment with TRAIL proteins. Cell apoptosis was measured by cell death enzyme-linked immunosorbent assay (ELISA). Values represent means±S.D. of three independent experiments (\**P*\<0.05). For specificity control of caspase-9 inhibition by Z-LEHD-fmk, the H9 cells, a type I Fas signaling cells, were treated with FasL (Peprotech, Rocky Hill, NJ, USA), a death stimulus that does not require caspase-9, and Etoposide, a death stimulus that requires caspase-9. Cell apoptosis was measured by cell death ELISA. Values represent means±S.D. of three independent experiments (\**P*\<0.05)](cddis201481f3){#fig3}

![*H. pylori*-induced TRAIL sensitivity is dependent on Bid processing. (**a**) AGS cells were transfected with Bcl-2, followed by incubation with *H. pylori* and subsequently treated with TRAIL. Cell apoptosis was measured by cell death enzyme-linked immunosorbent assay (ELISA). Values represent means±S.D. of three independent experiments (\**P*\<0.05). (**b**) AGS cells were incubated with or without *H. pylori* followed by treatment with TRAIL at the indicated times. The expression of full-length and truncated Bid (22 and 15 kDa, respectively) was detected by western blotting. Membranes were also blotted with anti-*β*-actin mAb as a loading control. (**c**) Cells were transfected with scramble or Bid siRNA, followed by incubation with *H. pylori* and subsequently treated with TRAIL. Cell apoptosis was measured by cell death ELISA. Values represent means±S.D. of three independent experiments (\**P*\<0.05)](cddis201481f4){#fig4}

![*H. pylori* downregulates FLIP~S~ expression and enhances the TRAIL-induced DISC assembly. (**a**) AGS cells were incubated with increasing amounts of *H. pylori* (MOI 25, 50, 100, 200) for 12 h and subsequently treated with TRAIL. Cell lysates were analyzed by western blotting to detect the activation level of caspase-8. Actin expression was used as a protein loading control. (**b**) Cells were co-cultured with *H. pylori* for 12 h, stimulated with 1 *μ*g/ml FLAG-TRAIL combined with 2 *μ*g/ml anti-FLAG antibody or normal mouse IgG for 1 h, and cell lysates were precipitated with protein A agarose. Isolated receptor complexes (IP) were assessed for caspase-8, FLIP~S~, FADD, and DR5 by western blotting](cddis201481f5){#fig5}

![*H. pylori*-induced sensitization to TRAIL-induced apoptosis is via c-FLIP~S~ downregulation. (**a**) AGS cells were transfected with FLIP~S~ and pCMV mock control, followed by incubation with *H. pylori* and subsequently treated with TRAIL. Cell apoptosis was measured by cell death enzyme-linked immunosorbent assay. Values represent means±S.D. of three independent experiments (\**P*\<0.05). (**b**) Cells were pretreated with 2 *μ*M MG132, a proteosome inhibitor, for 30 min before incubation with *H. pylori* (MOI 50,100, 200). After co-culture for 12 h, c-FLIP~S~ was determined by western blotting. The expression of actin serves as a loading control](cddis201481f6){#fig6}

![Knockdown of endogenous c-FLIP~S~ enhances TRAIL-mediated apoptosis in human gastric epithelial cells. (**a**) AGS cells were transfected with scramble or c-FLIP~S~ siRNA, followed by treatment with TRAIL. Cell apoptosis was measured by cell death enzyme-linked immunosorbent assay. Values represent means±S.D. of three independent experiments (\**P*\<0.05). (**b**) AGS cells were transfected with scramble or c-FLIP~S~ siRNA, followed by treatment with TRAIL. The cell lysate was subjected to western blotting analysis for detection of caspase activation. The expression of actin serves as a loading control](cddis201481f7){#fig7}
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